AngioDynamics Foresees New Laser Sales Opportunities With Sotradecol Drug
This article was originally published in The Gray Sheet
Executive Summary
AngioDynamics expects to expand into hitherto untargeted markets with the help of its newly licensed Sotradecol drug for the treatment of small, uncomplicated varicose veins
You may also be interested in...
People In Brief
FoxHollow loses CEO: President & CEO Robert Thomas resigns, effective Jan. 1. Thomas, who joined the SilverHawk plaque excision system manufacturer in 1998 and has been CEO since 2000, announced plans to retire Dec. 12. Founder and Chairman John Simpson steps in as interim CEO while the firm searches for a permanent replacement. The 44-year-old Thomas cited personal reasons for his departure, but some analysts question that explanation, according to reports in the Wall Street Journal. FoxHollow's stock has fallen sharply, closing Jan. 5 at $30.12, down 35% from $46.44 Dec. 9, the last trading day before the announcement...
People In Brief
FoxHollow loses CEO: President & CEO Robert Thomas resigns, effective Jan. 1. Thomas, who joined the SilverHawk plaque excision system manufacturer in 1998 and has been CEO since 2000, announced plans to retire Dec. 12. Founder and Chairman John Simpson steps in as interim CEO while the firm searches for a permanent replacement. The 44-year-old Thomas cited personal reasons for his departure, but some analysts question that explanation, according to reports in the Wall Street Journal. FoxHollow's stock has fallen sharply, closing Jan. 5 at $30.12, down 35% from $46.44 Dec. 9, the last trading day before the announcement...
Diomed v. Total Vein Solutions
Patent suit is filed over varicose vein endovascular laser treatment, Diomed says April 5. Separate actions are pending against AngioDynamics and Vascular Solutions (1"The Gray Sheet" Dec. 22, 2003, p. 6)...